Applications Open for the ESMO Patient Engagement Summit 2026
ESMO – European Society for Medical Oncology, shared a post on LinkedIn: “ESMO is inviting patient advocates from across the Asia-Pacific region to apply for the ESMO Patient Engagement Summit […]
Read the full articleYou might also wanna read
European Multiple Myeloma Patients Face Unequal Access to Curative Treatments
Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

Hallmarks of setting up a successful patient advocacy group
Patient advocacy has the potential to contribute to effective cancer care with real-world impact, regardless of a country’s socioeconomic st
Patient and Public Involvement opportunities in ME/CFS and other research
Sorry this isn’t very detailed but saw this on bluesky and thought worth sharing. Should I share in the Australia thread too/instead? Thanks
GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer
GSK announced submission of MAA to EMEA for pazopanib, oral therapy for metastatic renal cell carcinoma (RCC).
OMS: 92% da população global será impactada pelo câncer; entenda
A Organização Mundial da Saúde (OMS) avalia que o câncer se tornará uma experiência praticamente universal nos próximos anos. Segundo um lev
Join us to support Breast Cancer Foundation NZ this May
Every year in May, thousands of people across Aotearoa NZ gather to do something simple but powerful: they break bread together to raise fun

Comments
Sign in to join the conversation.
No comments yet. Be the first.